HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside.

Abstract
1. Cases of Gaucher's disease could not be distinguished from controls by the assay of beta-glucosidase activity in water homogenates of liver using 4-methylumbelliferyl-beta-D glucopyranoside. 2. Two peaks of beta-glucosidase activity were separated by Sephadex G-150 gel filtration in control and Gaucher livers. In the presence of the elution buffer pH profiles of peak I showed a deficiency at pH 3.5-4.5 in Gaucher's disease. Gaucher and control peak II had similar pH profiles with little or no activity at pH 3.0-4.0. 3. A clear distinction between homogenates of Gaucher and control liver was obtained by assay at pH 4.0 in the presence of elution buffer, or of sodium chloride, a component of the elution buffer.
AuthorsD M Broadhead, J Butterworth
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 75 Issue 1 Pg. 155-61 (Feb 15 1977) ISSN: 0009-8981 [Print] Netherlands
PMID14796 (Publication Type: Journal Article)
Chemical References
  • Glucosides
  • Umbelliferones
  • 4-methylumbelliferyl glucoside
  • Hymecromone
  • Glucosidases
  • Glucuronidase
Topics
  • Gaucher Disease (diagnosis)
  • Glucosidases (analysis)
  • Glucosides
  • Glucuronidase (analysis)
  • Humans
  • Hydrogen-Ion Concentration
  • Hymecromone (analogs & derivatives)
  • Liver (enzymology)
  • Umbelliferones

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: